531
Views
12
CrossRef citations to date
0
Altmetric
Retina

Disparities in the Global Burden of Age-Related Macular Degeneration: An Analysis of Trends from 1990 to 2015

, , , & ORCID Icon
Pages 657-663 | Received 26 Oct 2018, Accepted 24 Jan 2019, Published online: 18 Feb 2019

References

  • Bourne RR, Stevens GA, White RA, Smith JL, Flaxman SR, Price H, Jonas JB, Keeffe J, Leasher J, Naidoo K, et al. Causes of vision loss worldwide, 1990-2010: a systematic analysis. Lancet Glob Health. 2013;1(6):e339–49. doi:10.1016/S2214-109X(13)70113-X.
  • Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–16. doi:10.1016/S2214-109X(13)70145-1.
  • Saxena N, George PP, Hoon HB, Han LT, Onn YS. Burden of wet age-related macular degeneration and its economic implications in singapore in the year 2030. Ophthalmic Epidemiol. 2016;23(4):232–37. doi:10.1080/09286586.2016.1193617.
  • Rein DB, Zhang P, Wirth KE, Lee PP, Hoerger TJ, McCall N, Klein R, Tielsch JM, Vijan S, Saaddine J. The economic burden of major adult visual disorders in the united states. Arch Ophthalmol. 2006;124(12):1754–60. doi:10.1001/archopht.124.12.1754.
  • Lim LS, Mitchell P, Seddon JM, Holz FG, Wong TY. Age-related macular degeneration. Lancet. 2012;379(9827):1728–38. doi:10.1016/S0140-6736(12)60282-7.
  • GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (dalys) for 315 diseases and injuries and healthy life expectancy (hale), 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1603–58. doi:10.1016/S0140-6736(16)31460-X.
  • Ono K, Hiratsuka Y, Murakami A. Global inequality in eye health: country-level analysis from the global burden of disease study. Am J Public Health. 2010;100(9):1784–88. doi:10.2105/AJPH.2009.187930.
  • GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet. 2016;388(10053):1545–602. doi:10.1016/S0140-6736(16)31678-6.
  • Wang W, Yan W, Muller A, He M. A global view on output and outcomes of cataract surgery with national indices of socioeconomic development. Invest Ophthalmol Vis Sci. 2017;58(9):3669–76. doi:10.1167/iovs.17-21489.
  • Wang W, Yan W, Fotis K, Prasad NM, Lansingh VC, Taylor HR, Finger RP, Facciolo D, He M. Cataract surgical rate and socioeconomics: a global study. Invest Ophthalmol Vis Sci. 2016;57(14):5872–81. doi:10.1167/iovs.16-19894.
  • Wang W, Yan W, Müller A, Keel SE, He M. Socioeconomics and prevalence of visual impairment and blindness: a global analysis. JAMA Ophthalmol. 2017;135(11):1–8. doi:10.1001/jamaophthalmol.2017.3449.
  • Lou L, Yao C, Jin Y, Perez V, Ye J. Global patterns in health burden of uncorrected refractive error. Invest Ophthalmol Vis Sci. 2016;57(14):6271–77. doi:10.1167/iovs.16-20242.
  • He M, Wang W, Huang W. Variations and trends in health burden of visual impairment due to cataract: a global analysis. Invest Ophthalmol Vis Sci. 2017;58(10):4299–306. doi:10.1167/iovs.17-21459.
  • Global Burden of Disease Study 2015. Global burden of disease study 2015 (gbd 2015) results. Seattle, united states: institute for health metrics and evaluation (ihme); 2016 [ accessed 2017 Aug 1]. http://ghdx.healthdata.org/gbd-results-tool.
  • Bourne R, Flaxman SR, Braithwaite T, Cicinelli MV, Das A, Jonas JB, Keeffe J, Kempen JH, Leasher J, Limburg H, et al. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis. Lancet Glob Health. 2017;5(9):e888–97. doi:10.1016/S2214-109X(17)30293-0.
  • United Nations, Development Programme. Human development report 2016. New york: pbm graphics, 2016. [ accessed 2017 Aug 1]. http://hdr.undp.org/en/data.
  • Jonas JB, Bourne RR, White RA, Flaxman SR, Keeffe J, Leasher J, Naidoo K, Pesudovs K, Price H, Wong TY, et al. Visual impairment and blindness due to macular diseases globally: a systematic review and meta-analysis. Am J Ophthalmol. 2014;158(4):808–15. doi:10.1016/j.ajo.2014.06.012.
  • Joachim N, Mitchell P, Burlutsky G, Kifley A, Wang JJ. The incidence and progression of age-related macular degeneration over 15 years: the blue mountains eye study. Ophthalmology. 2015;122(12):2482–89. doi:10.1016/j.ophtha.2015.08.002.
  • Kawasaki R, Yasuda M, Song SJ, Chen SJ, Jonas JB, Wang JJ, Mitchell P, Wong TY. The prevalence of age-related macular degeneration in asians: a systematic review and meta-analysis. Ophthalmology. 2010;117(5):921–27. doi:10.1016/j.ophtha.2009.10.007.
  • Gilbert CE, Lepvrier-Chomette N. Gender inequalities in surgery for bilateral cataract among children in low-income countries: a systematic review. Ophthalmology. 2016;123(6):1245–51. doi:10.1016/j.ophtha.2016.01.048.
  • Cackett P, Tay WT, Aung T, Wang JJ, Shankar A, Saw SM, Mitchell P, Wong TY. Education, socio-economic status and age-related macular degeneration in asians: the singapore malay eye study. Br J Ophthalmol. 2008;92(10):1312–15. doi:10.1136/bjo.2007.136077.
  • Mahr MA, Hayes SN, Shanafelt TD, Sloan JA, Erie JC. Gender differences in physician service provision using medicare claims data. Mayo Clin Proc. 2017;92(6):870–80. doi:10.1016/j.mayocp.2017.02.017.
  • Finger RP, Xie J, Fotis K, Parikh S, Cummins R, Mitchell P, Guymer RH. Disparities in access to anti-vascular endothelial growth factor treatment for neovascular age-related macular degeneration. Clin Exp Ophthalmol. 2017;45(2):143–51. doi:10.1111/ceo.12804.
  • Parikh R, Ross JS, Sangaralingham LR, Adelman RA, Shah ND, Barkmeier AJ. Trends of anti-vascular endothelial growth factor use in ophthalmology among privately insured and medicare advantage patients. Ophthalmology. 2017;124(3):352–58. doi:10.1016/j.ophtha.2016.10.036.
  • Guthold R, Stevens GA, Riley LM, Bull FC. Worldwide trends in insufficient physical activity from 2001 to 2016: a pooled analysis of 358 population-based surveys with 1.9 million participants. Lancet Glob Health. 2018;6(10):e1077–86. doi:10.1016/S2214-109X(18)30357-7.
  • Williams PT. Prospective study of incident age-related macular degeneration in relation to vigorous physical activity during a 7-year follow-up. Invest Ophthalmol Vis Sci. 2009;50(1):101–06. doi:10.1167/iovs.08-2165.
  • McGuinness MB, Le J, Mitchell P, Gopinath B, Cerin E, Saksens N, Schick T, Hoyng CB, Guymer RH, Finger RP. Physical activity and age-related macular degeneration: a systematic literature review and meta-analysis. Am J Ophthalmol. 2017;180:29–38. doi:10.1016/j.ajo.2017.05.016.
  • Meyers KJ, Liu Z, Millen AE, Iyengar SK, Blodi BA, Johnson E, Snodderly DM, Klein ML, Gehrs KM, Tinker L, et al. Joint associations of diet, lifestyle, and genes with age-related macular degeneration. Ophthalmology. 2015;122(11):2286–94. doi:10.1016/j.ophtha.2015.07.029.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.